Corcept Therapeutics Incorporated (CORT) financials · rev $761.4M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Corcept Therapeutics Incorporated (CORT) rev $761.4M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $761.4M | $675.0M |
| Cost of Revenue | $13.0M | $10.9M |
| Gross Profit | $748.4M | $664.2M |
| Operating Income | $44.8M | $137.0M |
| Net Income | $99.7M | $141.2M |
| EPS (Diluted) | $0.82 | $1.23 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $836.7M | $840.6M |
| Current Assets | $485.5M | $471.6M |
| Cash & Equivalents | $120.5M | $127.7M |
| Inventory | $12.9M | $12.4M |
| PP&E | $1.89M | $2.69M |
| Total Liabilities | $188.8M | $161.0M |
| Current Liabilities | $166.1M | $140.8M |
| Shareholders' Equity | $647.8M | $679.6M |
| Retained Earnings | $643.4M | $543.7M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | $142.0M | $198.1M |
| CapEx | $211.0K | $2.17M |
| Investing Cash Flow | $69.8M | -$177.6M |
| Financing Cash Flow | -$220.4M | -$28.3M |
| Net Change in Cash | -$7.17M | -$7.89M |
| Free Cash Flow | $141.8M | $195.9M |
FAQ
What is CORT P/E and revenue?
Corcept Therapeutics Incorporated (CORT) rev $761.4M.
What is CORT revenue?
Corcept Therapeutics Incorporated last cached revenue is $761.4M (FY2025).
Is CORT profitable?
Corcept Therapeutics Incorporated last cached net income is $99.7M (FY2025).
What are CORT total assets?
Corcept Therapeutics Incorporated last cached total assets are $836.7M (FY2025).
What is CORT free cash flow?
Corcept Therapeutics Incorporated last cached free cash flow is $141.8M (FY2025).
Not investment advice. Cached statements, not a live tape.